| Assessment Status | Rapid Review complete |
| HTA ID | 19045 |
| Drug | Co-enzyme Q10 |
| Brand | CoQun® eye drops |
| Indication | As a complementary add-on treatment to antihypertensive glaucoma therapy. |
| Assessment Process | |
| Rapid review commissioned | 16/10/2019 |
| Rapid review completed | 13/01/2020 |
| Rapid review outcome | A full HTA is not recommended. The NCPE recommends that CoQ10 eye drops not be considered for reimbursement*. |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.